After many decades of effort, the future of gene and cell therapies is incredibly promising. While these technologies were initially developed in the context of treating rare diseases caused by a single faulty gene, a variety of gene and cell-based therapies for both rare and common diseases are currently in development.
BioRN Annual Conference: “NEXT-GENERATION Cell & Gene Therapies” will gather experts in this field on September 29 in Heidelberg.
Confirmed Speakers:
- KEYNOTE: Anke Schulte, Head of Cell & Gene Therapy Research and Preclinical Development, Bayer
- Carsten Müller-Tidow, University Hospital Heidelberg
- Ulrike Philippar, Johnson & Johnson
- Michael Platten, German Cancer Research Center
Profit from top information in CGT field, lively discussion and networking opportunities. Tap into one of the most innovative life science ecosystems in Europe.
WHEN: 29 September (9:00 – 17:00)
WHERE: Heidelberg (halle02, Zollhofgarten 2, 69115 Heidelberg)
REGISTRATION: https://www.biorn.org/biorn-annual-conference
CONTACT: az@biorn.org
MVA members can register with a 20% discount by entering the cluster association “MVA” when they register.